Ovid Therapeutics clinical trials we track

Check company identity source

Phase 3 1 trial

TrialDrugs studiedStatusPrimary completion
A Study of OV101 in Individuals With Angelman Syndrome (AS)NCT04106557GaboxadolCompleted2020-11-02Actual

Phase 2 1 trial

TrialDrugs studiedStatusPrimary completion
A Study of OV101 in Individuals With Fragile X SyndromeNCT03697161OV101 (gaboxadol)Completed2020-02-03Actual

Drugs in these trials

Names as written in the registry records.

Latest recorded trial changes

Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.